• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.01% Nasdaq Up0.31%

    Aeolus Pharmaceuticals Inc. (AOLS)

    -Other OTC
    0.28 Up 0.02(7.69%) 11:14AM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Sep 30, 2013Sep 30, 2012
    Total Revenue 9,631   3,928   7,293  
    Cost of Revenue -   -   -  
    Gross Profit 9,631   3,928   7,293  
    Operating Expenses
    Research Development6,966  3,360  6,468  
    Selling General and Administrative2,745  3,266  3,196  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (80) (2,698) (2,371)
    Income from Continuing Operations
    Total Other Income/Expenses Net -  (510)4,069  
    Earnings Before Interest And Taxes(80)(3,208)1,698  
    Interest Expense -   -   -  
    Income Before Tax(80)(3,208)1,698  
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(80)(3,208)1,698  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (80) (3,208) 1,698  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (80) (3,208) 1,698  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.